Meda AB, the Swedish maker of the Dymista allergy medicine, has had “preliminary contact” with Mylan Inc., Chairman Bert-Ake Eriksson told a local news agency today, amid reports the U.S. company may make a takeover offer.
Christie Hefner, former chief executive officer of Playboy Enterprises Inc., said she was shocked as her husband of 15 years, William Marovitz, confessed to her that he was being investigated for suspicious trading in Playboy shares. They were in their apartment atop a 42-story Lincoln Park tower overlooking the glittering Chicago skyline and Lake Michigan on a March evening in 2010.
Mylan Inc.’s $1.6 billion acquisition of a Strides Arcolab Ltd. unit has been put on hold as Indian regulators raise concern about foreign ownership of companies that make cancer drugs, the Economic Times reported.
Ex-Lehman Brothers Holdings Inc. broker Matthew Devlin, who cooperated with a U.S. probe of insider trading, was sentenced to three years of probation after prosecutors cited his “noteworthy” assistance.
A lobbying effort by drugmaker Mylan Inc. and others for schools to stock products that treat severe allergic reactions, like the company’s popular EpiPen, has accomplished something rare in Washington: uniting Congress.